Home
About
Overview
Sharing Data
ORCID
Help
History (5)
Artificial Intelligence for the Treatment of Lumbar Spondylolisthesis.
First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies.
Impaired hepatocyte glucose transport protein (GLUT2) internalization in chronic pancreatitis.
Role of macrolide therapy in chronic obstructive pulmonary disease.
Ultrasound and caudal blocks in children.
See All 5 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Artificial Intelligence for the Treatment of Lumbar Spondylolisthesis.
Ghogawala Z, Dunbar M, Essa I. Artificial Intelligence for the Treatment of Lumbar Spondylolisthesis. Neurosurg Clin N Am. 2019 Jul; 30(3):383-389.
View in:
PubMed
subject areas
Artificial Intelligence
Decompression, Surgical
Humans
Lumbar Vertebrae
Spinal Stenosis
Spondylolisthesis
Treatment Outcome
authors with profiles
Zoher Ghogawala MD, FACS